Apellis Pharmaceuticals, Inc. Underwriting Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement between Apellis Pharmaceuticals, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, and Evercore Group L.L.C. (February 22, 2023)
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2023
Apellis Pharmaceuticals, Inc. Underwriting Agreement for Common Stock Offering with J.P. Morgan, Goldman Sachs, and Evercore
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2022
Apellis Pharmaceuticals, Inc. Underwriting Agreement with J.P. Morgan, Goldman Sachs, and Evercore (8,750,000 Shares)
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2021
Apellis Pharmaceuticals, Inc. Underwriting Agreement with Citigroup, J.P. Morgan, and Evercore for Common Stock Offering
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2020
Underwriting Agreement between Apellis Pharmaceuticals, Inc. and Underwriters for Common Stock Offering (March 6, 2019)
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2019
Underwriting Agreement between Apellis Pharmaceuticals, Inc. and Underwriters (Citigroup, J.P. Morgan, Cowen) for Common Stock Offering
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2018
Underwriting Agreement between Apellis Pharmaceuticals, Inc. and Underwriters (Citigroup, J.P. Morgan, Evercore) for Common Stock Offering
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2017